Subject(s)
Autoantibodies , Autoantigens , B-Lymphocytes , Collagen Type XVII , Immunoglobulin A , Immunoglobulin G , Non-Fibrillar Collagens , Pemphigoid, Benign Mucous Membrane , Humans , Autoantibodies/immunology , Immunoglobulin A/immunology , Pemphigoid, Benign Mucous Membrane/immunology , Pemphigoid, Benign Mucous Membrane/diagnosis , Non-Fibrillar Collagens/immunology , Immunoglobulin G/immunology , Autoantigens/immunology , B-Lymphocytes/immunology , Female , Male , AgedABSTRACT
In this study, we generated a new set of monoclonal antibodies (mAbs) to bovine and human type VII collagen (COL7) by immunizing mice with bovine cornea-derived basement membrane zone (BMZ) fraction. The four mAbs, tentatively named as COL7-like mAbs, showed speckled subepidermal staining in addition to linear BMZ staining of normal human skin and bovine cornea, a characteristic immunofluorescence feature of COL7, but showed no reactivity with COL7 by in vitro biochemical analyses. Taking advantage of the phenomenon that COL7-like mAbs did not react with mouse BMZ, we compared immunofluorescence reactivity between wild-type and COL7-rescued humanized mice and found that COL7-like mAbs reacted with BMZ of COL7-rescued humanized mice. In ELISAs, COL7-like mAbs reacted with intact triple-helical mammalian recombinant protein (RP) of COL7 but not with bacterial RP. Furthermore, COL7-like mAbs did not react with COL7 within either cultured DJM-1 cells or basal cells of skin of a bullous dermolysis of the newborn patient. These results confirmed that COL7-like mAbs reacted with human and bovine COL7. The epitopes for COL7-like mAbs were considered to be present only on mature COL7 after secretion from keratinocytes and deposition to BMZ and to be easily destroyed during immunoblotting procedure. Additional studies indicated association of the speckled subepidermal staining with both type IV collagen and elastin. These unique anti-COL7 mAbs should be useful in studies of both normal and diseased conditions, particularly dystrophic epidermolysis bullosa, which produces only immature COL7.
Subject(s)
Basement Membrane/metabolism , Collagen Type VII/immunology , Collagen Type VII/metabolism , Animals , Antibodies, Monoclonal/biosynthesis , Cattle , HEK293 Cells , Humans , MiceABSTRACT
Branched-chain amino acids (BCAAs), viz., L-isoleucine, L-leucine, and L-valine, are essential amino acids that cannot be synthesized in higher organisms and are important nutrition for humans as well as livestock. They are also valued as synthetic intermediates for pharmaceuticals. Therefore, the demand for BCAAs in the feed and pharmaceutical industries is increasing continuously. Traditional industrial fermentative production of BCAAs was performed using microorganisms isolated by random mutagenesis. A collection of these classical strains was also scientifically useful to clarify the details of the BCAA biosynthetic pathways, which are tightly regulated by feedback inhibition and transcriptional attenuation. Based on this understanding of the metabolism of BCAAs, it is now possible for us to pursue strains with higher BCAA productivity using rational design and advanced molecular biology techniques. Additionally, systems biology approaches using augmented omics information help us to optimize carbon flux toward BCAA production. Here, we describe the biosynthetic pathways of BCAAs and their regulation and then overview the microorganisms developed for BCAA production. Other chemicals, including isobutanol, i.e., a second-generation biofuel, can be synthesized by branching the BCAA biosynthetic pathways, which are also outlined.
Subject(s)
Amino Acids, Branched-Chain/biosynthesis , Amino Acids, Branched-Chain/genetics , Amino Acids/biosynthesis , Bacterial Physiological Phenomena , Bioreactors/microbiology , Metabolic Engineering/methods , Amino Acids/genetics , Bacterial Proteins/physiology , Biological Products/metabolism , Fermentation/physiology , Genetic Enhancement/methodsABSTRACT
CD44, a cell surface proteoglycan, is involved in many biological events. CD44 transcripts undergo complex alternative splicing, resulting in many functionally distinct isoforms. To date, however, the nature of these isoforms in human epidermis has not been adequately determined. In this study, we isolated all CD44 transcripts from normal human epidermis, and studied how their expressions are regulated. By RT-PCR, we found that a number of different CD44 transcripts were expressed in human epidermis, and we obtained all these transcripts from DNA bands in agarose and acrylamide gels by cloning. Detailed sequence analysis revealed 18 CD44 transcripts, 3 of which were novel. Next, we examined effects of 10 different agents on the expression of CD44 transcripts in cultured human keratinocytes, and found that several agents, particularly epidermal growth factor, hydrogen peroxide, phorbol 12-myristate 13-acetate, retinoic acid, calcium and fetal calf serum differently regulated their expressions in various patterns. Furthermore, normal and malignant keratinocytes were found to produce different CD44 transcripts upon serum stimulation and subsequent starvation, suggesting that specific CD44 isoforms are involved in tumorigenesis via different CD44-mediated biological pathways.
Subject(s)
Epidermis/metabolism , Gene Expression Regulation/drug effects , Hyaluronan Receptors/genetics , Adult , Animals , Base Sequence , CHO Cells , Cricetinae , Cricetulus , Epidermal Cells , Exons/genetics , Genetic Variation , Humans , Keratinocytes/cytology , Keratinocytes/metabolism , Keratinocytes/pathology , Protein Isoforms/genetics , RNA, Messenger/genetics , RNA, Messenger/isolation & purification , Skin Neoplasms/pathologyABSTRACT
Previous studies of ocular mucous membrane pemphigoid (OMMP) have identified several components of the basement membrane zone to be autoantigens, including integrin ß4. However, there are no extensive or definitive reported studies that address this, particularly in pure OMMP. To clarify the major autoantigens in pure OMMP. In this study, we examined sera from 43 pure OMMP patients for both IgG and IgA antibodies using newly developed immunoblotting analyses with a hemidesmosome-rich fraction and various recombinant proteins of integrin α6ß4, in addition to our routine immune-serological tests. Using a hemidesmosome-rich fraction, sera from patients with pure OMMP demonstrated reactivity of IgG and/or IgA antibodies to integrin ß4, BP180 and laminin-332. The reactivity of pure OMMP sera to integrin ß4 was further confirmed by immunoblotting using integrin ß4 recombinant proteins. Using concentrated supernatant of HaCaT cells, only one serum sample showed positive IgG and IgA reactivity to LAD-1, the ectodomain of BP180. None of the pure OMMP sera reacted with any autoantigens on immunoblotting using normal human epidermal or dermal extracts, or purified human laminin-332. Integrin ß4 was considered to be the major and specific autoantigen for pure OMMP. The new methods established in this study are useful for detection of various autoantigens, particularly integrin ß4.
Subject(s)
Immunoglobulin A/blood , Immunoglobulin G/blood , Integrin beta4/immunology , Pemphigoid, Benign Mucous Membrane/blood , Autoantibodies/blood , Autoantigens/immunology , Case-Control Studies , Cell Adhesion Molecules/immunology , Fluorescent Antibody Technique, Indirect , Hemidesmosomes , Humans , Immunoblotting/methods , Non-Fibrillar Collagens/immunology , Pemphigoid, Benign Mucous Membrane/immunology , Recombinant Proteins/immunology , Kalinin , Collagen Type XVIIABSTRACT
OBJECTIVES: To confirm that sera from some BP patients reactive exclusively to the BP230 and to study the clinical and immunological characteristics of this condition. MATERIALS AND METHODS: BP patients were divided into three groups: BP reactive only to BP230 (BP230-BP), BP reactive to both BP180 and BP230 (BP180-BP230-BP) and BP reactive only to BP180 (BP180-BP), based on the results of standard ELISAs for BP180 and BP230. Clinical features were statistically analyzed among the three groups. Then, targeted epitopes in each group were studied by immunoblotting and novel ELISAs using three domain-specific BP230 recombinant proteins. RESULTS: Forty-one, 65 and 47 of 153 BP patients were categorized as BP230-BP, BP180-BP230-BP and BP180-BP, respectively. Clinically, BP230-BP patients showed significantly lower severity, less need of systemic steroids and better responses to various treatments, suggesting that BP230-BP is a milder condition. Immunoblotting and ELISAs of domain-specific BP230 recombinant proteins indicated that, while BP180-BP230-BP sera reacted with all three domains of BP230, BP230-BP sera reacted more frequently with epitopes in the BP230 C-terminal domain. CONCLUSION: We propose a new disease entity, named anti-BP230-type BP, in which anti-BP230 antibodies might be pathogenic and react specifically with the BP230 C-terminal domain. While anti-BP230 antibodies in BP180-BP230-BP seem to be produced via intermolecular epitope spreading, anti-BP230 antibodies in BP230-BP are considered to be produced by different mechanisms.
Subject(s)
Autoantibodies/blood , Autoantigens/immunology , Dystonin/immunology , Epitopes/immunology , Non-Fibrillar Collagens/immunology , Pemphigoid, Bullous/immunology , Aged , Enzyme-Linked Immunosorbent Assay/methods , Female , Humans , Male , Pemphigoid, Bullous/blood , Pemphigoid, Bullous/drug therapy , Recombinant Proteins/immunology , Retrospective Studies , Severity of Illness Index , Collagen Type XVIIABSTRACT
Although the major autoantigens in classic pemphigus are desmogleins, sera from various types of pemphigus react with a number of other molecules, including desmocollins and plakin proteins. However, other novel pemphigus-related autoantigens remain to be identified. In this study, immunoblotting for serum from an atypical autoimmune bullous disease patient identified an unknown 175 kDa protein. Subsequent studies using two-dimensional gel electrophoresis, immunoblotting and mass-spectrometry identified the 175 kDa protein as early endosome antigen 1 (EEA1). This finding was confirmed by subsequent immunological studies, including indirect immunofluorescence of skin and cultured keratinocytes, two-dimensional gel electrophoresis and immunoblotting with anti-EEA1 polyclonal antibody, and preabsorption with EEA1 recombinant protein. Finally, we developed a novel BIOCHIP assay using full-length EEA1 recombinant protein to detect anti-EEA1 antibodies. However, none of 35 sera from various types of pemphigus showed anti-EEA1 antibodies in the BIOCHIP assay, with the exception of the serum from the index case. In addition, various findings in the index case did not suggest pathogenic role of anti-EEA1 autoantibodies. Therefore, although we successfully identified the 175 kDa protein reacted by a serum of an atypical pemphigus-like patient as EEA1, novel BIOCHIP study for other pemphigus sera indicated that EEA1 is not a common and pathogenic autoantigen in pemphigus.
Subject(s)
Autoantibodies/immunology , Pemphigus/immunology , Vesicular Transport Proteins/immunology , Animals , COS Cells , Chlorocebus aethiops , Humans , Male , Middle AgedABSTRACT
All plakin family proteins are known to be autoantigens in paraneoplastic pemphigus (PNP). In this study, we first examined whether PNP sera also react with epiplakin, another plakin protein, by various immunological methods using 48 Japanese PNP sera. Immunofluorescence confirmed that cultured keratinocytes expressed epiplakin. Epiplakin was detected by 72.9% of PNP sera by immunoprecipitation-immunoblotting with KU-8 cell extract, but not by immunoblotting of either normal human epidermal extract or KU-8 cell extract. Epiplakin was essentially not detected by 95 disease and normal control sera. Statistical analyses of various clinical and immunological findings revealed a significant correlation of the presence of anti-epiplakin antibodies with both bronchiolitis obliterans and mortality. No epiplakin-negative PNP case developed bronchiolitis obliterans. However, although 29.4% of European patients with PNP had bronchiolitis obliterans, significant correlation with anti-epiplakin autoantibodies was not observed. In further studies for lung, immunofluorescence showed the presence of epiplakin in normal human lung, particularly respiratory bronchiole, immunoprecipitation-immunoblotting showed that PNP sera reacted with epiplakin in cultured lung cells, and mice injected with polyclonal antibody specific to epiplakin histopathologically showed abnormal changes in small airway epithelia. These results indicated that epiplakin is one of the major PNP autoantigens and is related to PNP-related bronchiolitis obliterans.
Subject(s)
Autoantigens/immunology , Autoantigens/metabolism , Bronchiolitis Obliterans/immunology , Paraneoplastic Syndromes/immunology , Pemphigus/immunology , Aged , Animals , Asian People/statistics & numerical data , Autoantibodies/blood , Biomarkers/blood , Bronchiolitis Obliterans/ethnology , Bronchiolitis Obliterans/metabolism , Cells, Cultured , Female , Fluorescent Antibody Technique , Humans , Immunoprecipitation , Keratinocytes/immunology , Keratinocytes/metabolism , Male , Mice , Middle Aged , Paraneoplastic Syndromes/ethnology , Paraneoplastic Syndromes/metabolism , Pemphigus/ethnology , Pemphigus/metabolism , Rats , Reference Values , Sampling Studies , Statistics, NonparametricABSTRACT
BACKGROUND: Since the original description by Zone et al in 1994, the disease entity and target antigens in linear IgA/IgG bullous dermatosis (LAGBD) have not been clarified in 20 years. OBJECTIVES: To determine autoantibodies and autoantigens in a new LAGBD case which showed atypical clinical and histopathological findings without apparent mucosal involvement. MATERIALS AND METHODS: We performed various indirect immunofluorescence and immunoblotting studies. RESULTS: Indirect immunofluorescence of 1M NaCl-split skin showed IgG and IgA reactivity with both epidermal and dermal sides. Immunoblotting studies using various antigen sources revealed circulating IgG and IgA antibodies reactive with laminin-332, laminin-γ1 and integrin α6ß4 in various patterns. Absorption study using recombinant proteins of laminin-γ1 indicated that the patient serum reacted with different epitopes between laminin-γ1 and laminin-γ2. CONCLUSIONS: This study presented for the first time a LAGBD patient with IgG and IgA antibodies to various laminins and integrins.
Subject(s)
Autoantibodies/blood , Integrins/metabolism , Laminin/metabolism , Linear IgA Bullous Dermatosis/immunology , Linear IgA Bullous Dermatosis/pathology , Administration, Oral , Administration, Topical , Adrenal Cortex Hormones/therapeutic use , Aged, 80 and over , Biopsy, Needle , Fluorescent Antibody Technique, Indirect , Follow-Up Studies , Humans , Immunohistochemistry , Integrins/immunology , Laminin/immunology , Linear IgA Bullous Dermatosis/drug therapy , Male , Risk Assessment , Severity of Illness Index , Treatment OutcomeABSTRACT
We report a 68-year-old Japanese female patient with subepidermal blistering disease with autoantibodies to multiple laminins, who subsequently developed membranous glomerulonephropathy. At skin disease stage, immunofluorescence demonstrated IgG anti-basement membrane zone antibodies reactive with dermal side of NaCl-split skin. Immunoblotting of human dermal extract, purified laminin-332, hemidesmosome-rich fraction and laminin-521 trimer recombinant protein (RP) detected laminin γ-1 and α-3 and γ-2 subunits of laminin-332. Three years after skin lesions disappeared, nephrotic symptoms developed. Antibodies to α-3 chain of type IV collagen (COL4A3) were negative, thus excluding the diagnosis of Goodpasture syndrome. All anti-laminin antibodies disappeared. Additional IB and ELISA studies of RPs of various COL4 chains revealed reactivity with COL4A5, but not with COL4A6 or COL4A3. Although diagnosis of anti-laminin γ-1 (p200) pemphigoid or anti-laminin-332-type mucous membrane pemphigoid could not be made, this case was similar to previous cases with autoantibodies to COL4A5 and/or COL4A6.
Subject(s)
Autoantibodies/analysis , Autoimmune Diseases/immunology , Blister/immunology , Collagen Type IV/immunology , Glomerulonephritis, Membranous/immunology , Kidney/immunology , Laminin/immunology , Skin/immunology , Aged , Autoantibodies/blood , Autoimmune Diseases/blood , Autoimmune Diseases/diagnosis , Autoimmune Diseases/therapy , Biopsy , Blister/blood , Blister/diagnosis , Blister/therapy , Female , Fluorescent Antibody Technique , Glomerulonephritis, Membranous/blood , Glomerulonephritis, Membranous/diagnosis , Glucocorticoids/therapeutic use , Humans , Kidney/ultrastructure , Plasma Exchange , Predictive Value of Tests , Protein Subunits , Skin/drug effects , Skin/pathology , Time FactorsSubject(s)
Autoantibodies/immunology , Laminin/immunology , Antibodies, Monoclonal/blood , Autoantibodies/blood , Epitopes/blood , Epitopes/immunology , Fluorescent Antibody Technique , Glycosylation , Humans , Immunoblotting , Immunologic Factors/blood , Immunologic Factors/immunology , Laminin/blood , Laminin/metabolism , Recombinant Proteins/blood , Recombinant Proteins/immunologyABSTRACT
In this study, we attempted to identify unknown autoantigen for intraepidermal neutrophilic IgA dermatosis-type IgA pemphigus by novel IgA-specific immunoprecipitation. Mass-spectrometry study identified polymeric immunoglobulin receptor (PIGR) as the candidate protein, and we confirmed that PIGR expressed in both epidermis and cultured keratinocytes. Eukaryotic recombinant protein of PIGR expressed in COS7 cells was reacted with both patient and normal sera, indicating that PIGR binds physiologically to IgA. To detect antigen-specific binding by IgA autoantibodies, we performed several experiments using deglycosylated PIGR and F(ab)2 fragments from patient sera. However, these analyses suggested that patient IgA bound physiologically, but not immunologically, to PIGR. Nevertheless, our study provided two important insights. Newly developed IgA-immunoprecipitation system should be a useful tool in the future study of identification of antigens for IgA autoantibodies. Detection of epidermal PIGR in this study confirmed previous results and indicated possible immunological role of PIGR in epidermis.
Subject(s)
Immunoglobulin A/blood , Immunoprecipitation/methods , Pemphigus/immunology , Receptors, Polymeric Immunoglobulin/blood , Autoantigens , Cells, Cultured , Epidermis/immunology , Eye Proteins , Humans , Keratinocytes , Neutrophils/immunology , Pemphigus/pathology , Peptide FragmentsABSTRACT
Although fibronectin (FN) is known as a chemoattractant for human dermal fibroblasts (HDFs), it is unclear whether HDF migration is stimulated by FN produced by HDFs (autocrine manner) or by keratinocytes (paracrine manner). In this study, we investigated HDF migration by Boyden chamber assay using conditioned media from HDFs and HaCaT cells (keratinocyte cell line). Immunoblotting and enzyme-linked immunosorbent assay revealed that FN existed in both conditioned media. Boyden chamber assay showed both conditioned media stimulated HDF migration, which was inhibited by anti-FN antibody. Antibodies to both integrin ß1and ß3 subunits inhibited HDF migration induced by HDF-conditioned medium almost completely and that by HaCaT cell-conditioned medium with 50-60%. These results suggested that HDF migration was stimulated by FN in both autocrine and paracrine manners. However, the mechanisms of HDF migration by FN, particularly the role of integrin ß1 and ß3 subunits, were slightly different between autocrine and paracrine manners.
Subject(s)
Fibroblasts/physiology , Fibronectins/physiology , Skin/cytology , Autocrine Communication , Cell Line , Cell Movement/physiology , Culture Media, Conditioned , Humans , Integrin beta1/physiology , Integrin beta3/physiology , Keratinocytes/physiology , Paracrine Communication , Skin Physiological PhenomenaABSTRACT
B-cell activating factor (BAFF), an important immune regulatory cytokine, is involved in development of autoimmune diseases. Although BAFF is expressed in various cells, including dendritic cells (DCs) and monocytes, BAFF expression on B cells has not been well documented. In the present study, BAFF molecules on DCs and naïve and memory B cells in autoimmune bullous diseases, including pemphigus vulgaris, pemphigus foliaceus and bullous pemphigoid (BP), were analysed by flow cytometry. Compared with healthy controls (HC), BAFF expression on naïve and memory B cells increased significantly in BP. No difference in BAFF receptor expression in naïve and memory B cells was shown among all study groups. Furthermore, BAFF expression in both naïve and memory B cells of BP, but not HC, was detected by confocal microscopic analysis. These results implied that BAFF expressed by B cells may play a pathogenic role in autoimmune bullous diseases, particularly BP.
Subject(s)
B-Cell Activating Factor/metabolism , B-Lymphocytes/metabolism , Pemphigoid, Bullous/metabolism , B-Lymphocytes/pathology , Case-Control Studies , Humans , Langerhans Cells/metabolism , Langerhans Cells/pathology , Microscopy, Confocal , Pemphigoid, Bullous/pathology , Pemphigus/metabolism , Pemphigus/pathologyABSTRACT
In sporotrichosis, dermal dendritic cells were considered to participate in induction of the immune responses against Sporothrix schenckii infection. However, it is still unclear whether and how dermal dendritic cells were involved in the progress. To clarify the pathogenic role of dermal dendritic cells (DC) in sporotrichosis, we examined the phagocytosis, maturation stages, cytokine production and antigen-presenting ability of mouse bone marrow-derived DC after stimulation with S. schenckii. By analysis of flow cytometry, electron microscope and confocal microscope, mouse bone marrow-derived DC were proved to be able to phagocytize the S. schenckii. The increased expression of CD40, CD80 and CD86 on the surface of S. schenckii-pulsed mouse bone marrow-derived DC was detected by flow cytometer, indicating that the S. schenckii-pulsed mouse bone marrow-derived DC underwent the maturation program. The secretory enhancement of interleukin (IL)-12, but not IL-4, was found in S. schenckii-pulsed mouse bone marrow-derived DC, suggesting the possible activation of T-helper 1 prone immune responses. Furthermore, S. schenckii-pulsed mouse bone marrow-derived DC were demonstrated to be capable of inducing the proliferation of T lymphocytes from BALB/c mice that were pre-sensitized with S. schenckii. Together, all the results implied that dermal DC may participate in the induction of immune responses against S. schenckii infection in sporotrichosis.